Chemical Structure (Pirfenidone 01)
Chemical structure of pirfenidone, showing a pyridone ring bonded to a methyl-substituted pyridine and a phenyl group.*
Pirfenidone Capsule
Product Images NDC 76282-715
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 76282-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Pirfenidone 02)
A line chart comparing the percentage of patients experiencing changes in %Forced Vital Capacity (FVC) from baseline to week 52 between Pirfenidone and placebo groups. The x-axis represents absolute change in %FVC, while the y-axis shows the percentage of patients. The chart highlights worsening (decrease in %FVC) vs no decline (increase in %FVC) in patients for both treatments.*
Figure 2 (Pirfenidone 03)
Line graph showing mean change in FVC (mL) over 52 weeks comparing Pirfenidone and placebo groups. The y-axis represents mean change in FVC, and the x-axis represents weeks. The Pirfenidone group shows a less steep decline over time than the placebo group, indicating a slower reduction in FVC.*
Figure 3 (Pirfenidone 04)
A survival curve chart showing the percentage of patients alive over time in weeks, comparing Pirfenidone (n=623) with placebo (n=624). The chart includes a hazard ratio (HR) with 95% confidence intervals and numbers of patients at risk at various time points up to 120 weeks.*
Principal Display Panel (90 Capsules)
Label for Pirfenidone Capsules 267 mg by Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-715, states the capsule strength as 267 mg, and indicates a package size of 90 capsules. It lists storage instructions and manufacturing information for Exelan Pharmaceuticals, Inc. and ScieGen Pharmaceuticals, Inc.*
Principal Display Panel (270 Capsules)
Label for Pirfenidone Capsules 267 mg, an oral prescription drug by Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-715-27, specifies 270 capsules per container, and provides storage instructions and manufacturing details from Exelan Pharmaceuticals and ScieGen Pharmaceuticals.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
